Literature DB >> 18377794

Dyspepsia in childhood and adolescence: insights and treatment considerations.

Maria E Perez1, Nader N Youssef.   

Abstract

Functional dyspepsia (FD) is common in children, with as many as 80% of those being evaluated for chronic abdominal pain reporting symptoms of epigastric discomfort, nausea, or fullness. It is known that patients with persistent complaints have increased comorbidities such as depression and anxiety. The interaction with psychopathologic variables has been found to mediate the association between upper abdominal pain and gastric hypersensitivity. These observations suggest that abnormal central nervous system processing of gastric stimuli may be a relevant pathophysiologic mechanism in FD. Despite increased understanding, no specific therapy has emerged; however, recent nonpharmacological-based options such as hypnosis may be effective. Novel approaches, including dietary manipulation and use of nutraceuticals such as ginger and Iberogast (Medical Futures Inc., Ontario, Canada), may also be considered.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18377794     DOI: 10.1007/s11894-007-0058-4

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  73 in total

1.  Abdominal pain and irritable bowel syndrome in adolescents: a community-based study.

Authors:  J S Hyams; G Burke; P M Davis; B Rzepski; P A Andrulonis
Journal:  J Pediatr       Date:  1996-08       Impact factor: 4.406

2.  Pharmacological basis for the medicinal use of ginger in gastrointestinal disorders.

Authors:  Muhammad Nabeel Ghayur; Anwarul Hassan Gilani
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

3.  Visceral hyperalgesia in children with functional abdominal pain.

Authors:  C Di Lorenzo; N N Youssef; L Sigurdsson; L Scharff; J Griffiths; A Wald
Journal:  J Pediatr       Date:  2001-12       Impact factor: 4.406

4.  Omeprazole for severe reflux esophagitis in children.

Authors:  C De Giacomo; P Bawa; M Franceschi; O Luinetti; R Fiocca
Journal:  J Pediatr Gastroenterol Nutr       Date:  1997-05       Impact factor: 2.839

5.  The effect of ranitidine (as effervescent tablets) on the quality of life of GORD patients.

Authors:  J H Stacey; M L Miocevich; G E Sacks
Journal:  Br J Clin Pract       Date:  1996-06

6.  Assessment of gastric sensorimotor function in paediatric patients with unexplained dyspeptic symptoms and poor weight gain.

Authors:  I Hoffman; R Vos; J Tack
Journal:  Neurogastroenterol Motil       Date:  2007-03       Impact factor: 3.598

7.  Clinical efficacy and pharmacokinetics of montelukast in dyspeptic children with duodenal eosinophilia.

Authors:  Craig A Friesen; Gregory L Kearns; Linda Andre; Mark Neustrom; Charles C Roberts; Susan M Abdel-Rahman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-03       Impact factor: 2.839

8.  Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome: a randomized controlled trial.

Authors:  Arine M Vlieger; Carla Menko-Frankenhuis; Simone C S Wolfkamp; Ellen Tromp; Marc A Benninga
Journal:  Gastroenterology       Date:  2007-09-02       Impact factor: 22.682

9.  Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia.

Authors:  V Stanghellini; C Tosetti; A Paternico; G Barbara; A M Morselli-Labate; N Monetti; M Marengo; R Corinaldesi
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

10.  Evaluation of guided imagery as treatment for recurrent abdominal pain in children: a randomized controlled trial.

Authors:  Joy A Weydert; Daniel E Shapiro; Sari A Acra; Cynthia J Monheim; Andrea S Chambers; Thomas M Ball
Journal:  BMC Pediatr       Date:  2006-11-08       Impact factor: 2.125

View more
  9 in total

Review 1.  Consequences of Helicobacter pylori infection in children.

Authors:  Lucia Pacifico; Caterina Anania; John F Osborn; Flavia Ferraro; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

2.  Fludrocortisone improves nausea in children with orthostatic intolerance (OI).

Authors:  John E Fortunato; Hossam A Shaltout; Megan M Larkin; Peter C Rowe; Debra I Diz; Kenneth L Koch
Journal:  Clin Auton Res       Date:  2011-07-28       Impact factor: 4.435

Review 3.  Functional gastrointestinal disorders: past and present.

Authors:  Rana Fayez Ammoury; Marian Del Rosario Pfefferkorn; Joseph Marino Croffie
Journal:  World J Pediatr       Date:  2009-07-09       Impact factor: 2.764

Review 4.  Gastroparesis in children.

Authors:  Efstratios Saliakellis; Maria Fotoulaki
Journal:  Ann Gastroenterol       Date:  2013

Review 5.  Integrative Therapies and Pediatric Inflammatory Bowel Disease: The Current Evidence.

Authors:  Sanghamitra M Misra
Journal:  Children (Basel)       Date:  2014-08-25

6.  Association of anxiety, depression, and psychological distress in people with and without functional dyspepsia.

Authors:  Peyman Adibi; Ammar Hasanzadeh Keshteli; Hamed Daghaghzadeh; Hamidreza Roohafza; Nasim Pournaghshband; Hamid Afshar
Journal:  Adv Biomed Res       Date:  2016-12-27

7.  Gut-directed hypnotherapy versus standard medical treatment for nausea in children with functional nausea or functional dyspepsia: protocol of a multicentre randomised trial.

Authors:  Pamela D Browne; Bibiche den Hollander; Esther M Speksnijder; Herbert M van Wering; Walther Tjon A Ten; Elvira K George; Michael Groeneweg; Nanja Bevers; Margaretha M S Wessels; Maartje M van den Berg; Joery Goede; Sarah T A Teklenburg-Roord; Carla Frankenhuis; Marc A Benninga; Arine M Vlieger
Journal:  BMJ Open       Date:  2019-04-11       Impact factor: 2.692

8.  Effectivity of treatment for children with functional dyspepsia.

Authors:  Corinne Légeret; Yvonne Stienen; Raoul Furlano; Henrik Köhler
Journal:  Sci Rep       Date:  2022-01-27       Impact factor: 4.379

9.  Efficacy and Safety of Shenqu Xiaoshi Oral Liquid Compared With Domperidone Syrup in Children With Functional Dyspepsia.

Authors:  Yi Yu; Xiao-Li Xie; Jie Wu; Zhong-Yue Li; Zhi-Gang He; Chun-Jie Liang; Zhong-Qin Jin; Ai-Zhen Wang; Jian Gu; Ying Huang; Hong Mei; Wei Shi; Si-Yuan Hu; Xun Jiang; Juan Du; Chi-Jun Hu; Li Gu; Mao-Lin Jiang; Zhi-Qin Mao; Chun-Di Xu
Journal:  Front Pharmacol       Date:  2022-02-04       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.